Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin N Rome

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Pediatrics|June 9, 2026
Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum DisordersBenjamin N Rome, John Kim, Jose F Figueroa, et al.
JAMA Internal Medicine|January 30, 2023
Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021Junyi Wang, ChangWon C Lee, Aaron S Kesselheim, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2024
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded IndicationsAnjali D Deshmukh, Aaron S Kesselheim, Theodore Tsacogianis, et al.
Annals of Internal Medicine|April 29, 2024
Estimated Medicare Part D Savings From Generic Drugs With a Skinny LabelAlexander C Egilman, Aaron S Kesselheim, Ameet Sarpatwari, et al.
JAMA Internal Medicine|March 9, 2026
Cost-Related Medication Nonadherence After the Inflation Reduction ActLucas X Marinacci, Stephen Mein, Benjamin N Rome, et al.
JAMA|May 14, 2025
Insurer Exits After the Inflation Reduction Act Part D RedesignChristopher L Cai, Aaron S Kesselheim, Anushka Bhaskar, et al.
The New England Journal of Medicine|October 11, 2023
Will Medicare Price Negotiation Delay Cancer-Drug Launches?Matthew Vogel, Aaron S Kesselheim, William B Feldman, et al.
JAMA Internal Medicine|August 18, 2025
Changes in Medicare Part D Plan Designs After the Inflation Reduction ActChristopher L Cai, Anushka Bhaskar, Aaron S Kesselheim, et al.
The New England Journal of Medicine|January 13, 2021
The Future of Drug-Pricing TransparencyWilliam B Feldman, Benjamin N Rome, Jerry Avorn, et al.
JAMA Internal Medicine|March 29, 2021
Frequency of First Generic Drug Approvals With "Skinny Labels" in the United StatesBryan S Walsh, Ameet Sarpatwari, Benjamin N Rome, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Pediatrics|June 9, 2026
Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum DisordersBenjamin N Rome, John Kim, Jose F Figueroa, et al.
JAMA Internal Medicine|January 30, 2023
Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021Junyi Wang, ChangWon C Lee, Aaron S Kesselheim, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2024
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded IndicationsAnjali D Deshmukh, Aaron S Kesselheim, Theodore Tsacogianis, et al.
Annals of Internal Medicine|April 29, 2024
Estimated Medicare Part D Savings From Generic Drugs With a Skinny LabelAlexander C Egilman, Aaron S Kesselheim, Ameet Sarpatwari, et al.
JAMA Internal Medicine|March 9, 2026
Cost-Related Medication Nonadherence After the Inflation Reduction ActLucas X Marinacci, Stephen Mein, Benjamin N Rome, et al.
JAMA|May 14, 2025
Insurer Exits After the Inflation Reduction Act Part D RedesignChristopher L Cai, Aaron S Kesselheim, Anushka Bhaskar, et al.
The New England Journal of Medicine|October 11, 2023
Will Medicare Price Negotiation Delay Cancer-Drug Launches?Matthew Vogel, Aaron S Kesselheim, William B Feldman, et al.
JAMA Internal Medicine|August 18, 2025
Changes in Medicare Part D Plan Designs After the Inflation Reduction ActChristopher L Cai, Anushka Bhaskar, Aaron S Kesselheim, et al.
The New England Journal of Medicine|January 13, 2021
The Future of Drug-Pricing TransparencyWilliam B Feldman, Benjamin N Rome, Jerry Avorn, et al.
JAMA Internal Medicine|March 29, 2021
Frequency of First Generic Drug Approvals With "Skinny Labels" in the United StatesBryan S Walsh, Ameet Sarpatwari, Benjamin N Rome, et al.
Pageof 14